BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 6151893)

  • 1. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockade and the effects of stress on the normal and ischaemic heart.
    Prichard BN
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S9-18. PubMed ID: 6118124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct size reduction: a review of the clinical trials.
    Campbell CA; Przyklenk K; Kloner RA
    J Clin Pharmacol; 1986; 26(5):317-29. PubMed ID: 2871053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockade in acute myocardial infarction.
    Cruickshank JM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S59-70. PubMed ID: 2468837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
    Prichard BN
    Z Kardiol; 1990; 79 Suppl 3():99-103. PubMed ID: 1983055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions during and after acute myocardial infarction.
    Sleight P
    Postgrad Med J; 1983; 59 Suppl 3():80-8. PubMed ID: 6139802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.